Here, we showed a trend that YBX1 mRNA levels were associated with a poor prognosis within the first five years of follow-up.
← all excerpts
The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF<sub>165</sub> and downregulating VEGF<sub>165b</sub>.
1
—
—